Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: A Study of E7389 in Advanced/Metastatic Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating eribulin (E7389) for advanced or metastatic breast cancer; results from the study were posted.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing lapatinib plus capecitabine to trastuzumab plus capecitabine in HER2-positive metastatic breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours [Phase 2]
Phase 2 proof-of-concept trial evaluating AZD4547 in FGFR1/FGFR2-amplified tumors, including gastric cancer, esophageal cancer, breast cance…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer [Phase 2]
An update on a Phase 2 trial evaluating TS-1 as second-line treatment for advanced metastatic breast cancer. The current status of the study…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction [NA]
A terminated clinical trial evaluated fibrin sealant to prevent fluid buildup during breast reconstruction surgery; results posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating etoposide for recurrent or metastatic breast cancer; the current status is not specified.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels
Dexamethasone reduces postoperative emesis by lowering PGF2α and LTC4 levels, according to a trial update involving thyroid and breast cance…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer [Phase 1]
The Phase 1 trial evaluating chemotherapy in combination with trastuzumab for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer [Phase 4]
This update notes the completion of a Phase 4 trial evaluating pemetrexed in combination with cisplatin for advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [Phase 3]
A Phase 3 trial evaluating a bone maintenance algorithm using a bisphosphonate in combination with Anastrozole for breast cancer has complet…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases [Phase 2]
Phase 2 trial of sagopilone (ZK219477) in patients with breast cancer and brain metastases was terminated; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update reporting on a combination of cisplatin, paclitaxel, and everolimus in metastatic breast cancer with Phase 1 and Phase…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating the combination of cisplatin, paclitaxel, and everolimus in patients with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Circadian Disturbances After Breast Cancer Surgery
This completed clinical trial update investigates circadian disturbances after breast cancer surgery, focusing on circadian rhythm disorders…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: RCT to Examine the Effects of Scanning [NA]
An RCT investigating the effects of a scanning intervention in cancer patients has completed, with indications including breast cancer and c…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Long Term Results of the Canadian Breast IMRT Study [Phase 3]
The document reports long-term results from a Phase 3 trial evaluating intensity-modulated radiotherapy for breast cancer in Canada.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women [Phase 2]
Phase 2 clinical trial evaluating preoperative combination therapy with everolimus and letrozole for primary breast cancer in postmenopausal…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant or adjuvant epirubicin, cyclophosphamide, and paclitaxel in women with Stage I–III breast ca…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]
A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer [Phase 2]
Phase 2 trial update for capecitabine and tipifarnib in taxane-resistant metastatic breast cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: ErbB2 Positive Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of ErbB2 (HER2) positive metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast [Phase 2]
A Phase 2 clinical trial evaluating gefitinib followed by surgery for ductal carcinoma in situ of the breast was terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors [Phase 2]
An update on a Phase 2 clinical trial evaluating the effects of physical activity and dietary changes in minority breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Cancer [Phase 1]
Phase 1 trial of a biological therapy in patients with metastatic cancer conducted by Duke University has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer [Phase 1, Phase 2]
Pfizer conducted a Phase 1/2 trial of bosutinib plus capecitabine in multiple solid tumors, including advanced breast cancer and pancreatic …